Pluri (PLUR) Current Leases (2019 - 2025)

Pluri (PLUR) reported Current Leases of $712000.0 for Q4 2025, up 19.66% year-over-year from $595000.0 in Q4 2024, and up 5.79% quarter-over-quarter from $673000.0 in Q3 2025.

Pluri (PLUR) Current Leases (2019 - 2025) Analysis & Trends

Pluri (PLUR) has 7 years of Current Leases data on file, last reported at $712000.0 in Q4 2025.

  • Current Leases for Q4 2025 came in at $712000.0, up 19.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $712000.0 (up 19.66% YoY), and the FY2025 annual result was $659000.0, up 17.89% from the prior year.
  • Current Leases grew to $712000.0 in Q4 2025 per PLUR's latest filing, from $673000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $826000.0 in Q1 2021 and troughed at $401000.0 in Q3 2021.
  • A 5-year average of $631550.0 and a median of $630500.0 in 2021 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2021 and 2022: Current Leases slumped 61.88% in 2021, then soared 52.37% in 2022.
  • A 5-year view of Current Leases shows it stood at $669000.0 in 2021, then declined by 9.57% to $605000.0 in 2022, then climbed by 8.1% to $654000.0 in 2023, then declined by 9.02% to $595000.0 in 2024, then grew by 19.66% to $712000.0 in 2025.
  • Business Quant data shows PLUR's Current Leases at $712000.0 in Q4 2025, $673000.0 in Q3 2025, and $659000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 83,991.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 7.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 712,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 712,000.00
Sep 30, 2025 673,000.00
Jun 30, 2025 659,000.00
Mar 31, 2025 599,000.00
Dec 31, 2024 595,000.00
Sep 30, 2024 574,000.00
Jun 30, 2024 559,000.00
Mar 31, 2024 675,000.00
Dec 31, 2023 654,000.00
Sep 30, 2023 643,000.00
Jun 30, 2023 627,000.00
Mar 31, 2023 627,000.00
Dec 31, 2022 605,000.00
Sep 30, 2022 611,000.00
Jun 30, 2022 619,000.00
Mar 31, 2022 669,000.00
Dec 31, 2021 669,000.00
Sep 30, 2021 401,000.00
Jun 30, 2021 634,000.00
Mar 31, 2021 826,000.00